Vr Adviser, LLC

Investment Portfolio & 13F Holdings Analysis

About
CIK: 0001615982
Type: FundHoldings: 37Value: $1.2BLatest: 2025Q1

VR Adviser, LLC is an institutional investment manager that filed its latest Form 13F for 2025Q1, reporting 37 holdings worth $1.2 billion. Form 13F filings provide transparency into the equity holdings of institutional investment managers with over $100 million in assets under management. This page displays the most recent portfolio holdings, allowing investors to track position changes, new investments, and portfolio composition.

Filing Details

13F-HR2025-03-31
Report Date
2025-03-31
Filing Date
2025-05-15
Total Holdings
37
Total Value
1175247364
Accession Number
0001415889-25-013093
Form Type
13F-HR
Manager Name
Vr-Adviser
Data Enrichment
89% identified
33 identified4 unidentified

Holdings

37 positions • $1.2B total value
Manager:
Search and click to pin securities to the top
Page 1 of 2
Apogee Therapeutics, Inc.
Shares:8.5M
Value:$317.3M
% of Portfolio:27.0% ($317.3M/$1.2B)
59267L107
Shares:3.8M
Value:$102.1M
% of Portfolio:8.7% ($102.1M/$1.2B)
OCULAR THERAPEUTIX, INC
Shares:12.8M
Value:$93.5M
% of Portfolio:8.0% ($93.5M/$1.2B)
Enliven Therapeutics, Inc.
Shares:4.0M
Value:$79.2M
% of Portfolio:6.7% ($79.2M/$1.2B)
KalVista Pharmaceuticals, Inc.
Shares:6.7M
Value:$77.4M
% of Portfolio:6.6% ($77.4M/$1.2B)
Viridian Therapeutics, Inc.\DE
Shares:3.9M
Value:$52.3M
% of Portfolio:4.5% ($52.3M/$1.2B)
Pharvaris N.V.
Shares:3.1M
Value:$48.9M
% of Portfolio:4.2% ($48.9M/$1.2B)
Spyre Therapeutics, Inc.
Shares:2.7M
Value:$43.3M
% of Portfolio:3.7% ($43.3M/$1.2B)
Oruka Therapeutics, Inc.
Shares:4.1M
Value:$42.6M
% of Portfolio:3.6% ($42.6M/$1.2B)
Praxis Precision Medicines, Inc.
Shares:990.0K
Value:$37.5M
% of Portfolio:3.2% ($37.5M/$1.2B)
Cogent Biosciences, Inc.
Shares:5.7M
Value:$34.0M
% of Portfolio:2.9% ($34.0M/$1.2B)
Dianthus Therapeutics, Inc. /DE/
Shares:1.7M
Value:$31.6M
% of Portfolio:2.7% ($31.6M/$1.2B)
Dyne Therapeutics, Inc.
Shares:2.2M
Value:$22.7M
% of Portfolio:1.9% ($22.7M/$1.2B)
Cidara Therapeutics, Inc.
Shares:1.1M
Value:$22.6M
% of Portfolio:1.9% ($22.6M/$1.2B)
29286M105
Shares:5.0M
Value:$22.6M
% of Portfolio:1.9% ($22.6M/$1.2B)
Erasca, Inc.
Shares:16.2M
Value:$22.2M
% of Portfolio:1.9% ($22.2M/$1.2B)
Oric Pharmaceuticals, Inc.
Shares:3.2M
Value:$17.8M
% of Portfolio:1.5% ($17.8M/$1.2B)
Upstream Bio, Inc.
Shares:2.3M
Value:$14.0M
% of Portfolio:1.2% ($14.0M/$1.2B)
Astria Therapeutics, Inc.
Shares:2.5M
Value:$13.1M
% of Portfolio:1.1% ($13.1M/$1.2B)
Cullinan Therapeutics, Inc.
Shares:1.4M
Value:$10.4M
% of Portfolio:0.9% ($10.4M/$1.2B)